Denali Advisors »

Fulcrum Therapeutics shares owned by Denali Advisors

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Denali Advisors from 13F filings

Historical chart of Denali Advisors investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Denali Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Denali Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $256k 27k 9.44
2023-12-31 $390k 58k 6.75
2023-09-30 $314k 71k 4.44
2022-06-30 $19k 3.9k 4.87
2022-03-31 $92k 3.9k 23.59
2021-12-31 $69k 3.9k 17.69